About CARI Health
CARI Health develops wearable medication monitors and point-of-care methadone dosing tools for clinicians. The system uses metabolic ratios to guide patient-specific adjustments and help patients reach therapeutic doses faster and more safely. Among surveyed clinicians, 74% considered methadone data at the point of care critical for the best patient care.
Patrik Schmidle founded the San Diego company and serves as chief executive officer. He leads clinicians and biochemical and electrical engineers, after six acquisitions in his earlier career. Gioia Messinger and Charles Patton are board directors. NIH funding totaled $318,257 in 2023, $318,172 in 2024, $1,447,789 in 2025 and $1,069,475 in 2026.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | Jul 21, 2025amended Nov 6, 2026 | $280,000of $1.0M target | 7 | $40,000 | Convertible Promissory NotesRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 18, 2023 | Feb 15, 2024 | $150,000of $3.0M target | 2 | $75,000 | Convertible Promissory NotesRule 506(b) | Form D ↗ |
| May 11, 2022 | Feb 14, 2024 | $2,300,000of $2.3M target | 11 | $209K | Convertible Promissory NotesRule 506(b) | Form D ↗ |
| May 11, 2022 | May 26, 2022 | $800,000of $2.2M target | 4 | $200K | Convertible Promissory Notes.Rule 506(b) | Form D ↗ |
| Total, four offerings | $3,530,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by CARI Health
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Jan 10, 2023 | Seed | $2.3M | Business Wire announcement ↗ | |
| Mar 24, 2022 | Angel conference award | $300,000+ | Business Wire announcement ↗ |
Why Investors Backed CARI Health
CARI Health makes tools that help clinicians personalize methadone dosing. Its system delivers patient-specific information at the point of care. The company has combined private financing with NIH support for its monitoring programs.
The problem it targets
Clinicians must balance speed and safety while moving patients toward a therapeutic methadone dose. CARI Health focuses on giving them actionable data during care. Among surveyed clinicians, 74% considered point-of-care methadone data critical for the best patient care.
What the product does
The product uses metabolic ratios to support dose adjustments for individual patients. It combines wearable medication monitoring with results available at the point of care. Federally funded programs include the Methadone Dosing System and an earlier Therapeutic Monitoring System.
Progress so far
NIH awards reached $318,257 in 2023 and $318,172 in 2024. Funding increased to $1,447,789 in 2025, followed by $1,069,475 in 2026. These awards supported methadone dosing and therapeutic monitoring programs.
Who backs it
CARI Health raised $2.3 million in a seed round announced January 10, 2023. It previously received more than $300,000 through the San Diego Angel Conference. NIH has supported its Methadone Dosing System and earlier medication-monitoring work.
We wrote this summary from public statements by CARI Health and its investors. It is not investment advice.
CARI Health in the News
Leadership Team
Executive officers and directors listed on CARI Health's Form D filed Nov 6, 2026.
